A number of other glycoproteins have also been proposed as potential CRC markers, using proteomics and genomics techniques, including EGFR, spectrins, carcinoembryonic antigen-related cell adhesion molecules (CEACAM), junction plakoglobin (JUP) and cadherin 17 (CDH17) [83,84,85,86]. This evidence concerns the gene JUP and colorectal carcinoma.